PBH
NYSE · Pharmaceuticals
Prestige Consumer Healthcare
$52.54
-2.05 (-3.76%)
Performance
1D
—
1W
—
1M
—
3M
-19.60%
6M
-13.27%
1Y
-40.32%
YTD
-14.18%
Open$54.12
Previous Close$54.59
Day High$54.77
Day Low$51.79
52W High$89.37
52W Low$51.24
Volume—
Avg Volume557.1K
Market Cap2.58B
P/E Ratio13.85
EPS$3.78
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$64.04
Below
SMA 200
$69.15
Below
RSI (14)
68.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+48.7% upside
Current
$52.54
$52.54
Target
$78.15
$78.15
$50.25
$78.15 avg
$108.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.12B | 1.10B | 462.83M |
| Net Income | 210.68M | 186.74M | 138.88M |
| Profit Margin | 18.9% | 17.9% | 30.0% |
| EBITDA | 346.66M | 324.33M | 217.92M |
| Free Cash Flow | — | — | 109.94M |
| Rev Growth | +1.5% | +1.5% | +15.0% |
| Debt/Equity | 0.55 | 0.55 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |